Published in Medical Letter on the CDC and FDA, July 18th, 2010
"To enable the detection of antimicrobial residues, a robust LC-MS/MS...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.